Skip to search formSkip to main contentSkip to account menu

methylnaltrexone

Known as: 17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium, morphinanium, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-17-methyl-6-oxo-, (5alpha)-, (5alpha)-17-(cyclopropylmethyl)-3,14-dihydroxy-17-methyl-4,5-epoxymorphinan-17-ium-6-one 
A methyl derivative of noroxymorphone with selective, opioid-receptor antagonistic activity. Methylnaltrexone displaces opioids from peripheral… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
PURPOSE: Postoperative ileus contributes to surgical morbidity and is associated with prolonged hospitalization and increased… 
Review
2007
Review
2007
Objectives: Opioid medications are frequently used in pain and palliative care patients with malignancy to manage symptoms such… 
1998
1998
Purpose: Morphine can have either an emetic or an antiemetic effect. The emetic effect of morphine can be blocked by… 
1994
1994
Methylnaltrexone (MNTX) is a quaternary derivative of naltrexone. It does not cross the blood-brain barrier and, thus, it… 
Highly Cited
1989
Highly Cited
1989
1. Rats and mice have a greater capacity than dogs or humans to N-demethylate the quaternary ammonium compound, N…